Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine and Naproxen for Pain Control During ESWL
NCT02786446Completed
- Sponsor
- Shifa International Hospital
- Start
- Jul 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of Lidocaine Hydrochloride Injection, without epinephrine and Aprol in nephrolithiasis, sponsored by Shifa International Hospital. Started Jul 2015; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrineAprol
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT02786446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02786446.